$SBRA
Sabra Health Care REIT, Inc.

2021 Q4 Form 10-Q Financial Statement

#000149229821000050 Filed on November 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $135.7M $128.6M $143.3M
YoY Change -10.81% -10.23% -4.39%
Cost Of Revenue $30.87M $29.96M $26.50M
YoY Change 14.77% 13.06% 10.42%
Gross Profit $104.8M $98.63M $116.7M
YoY Change -16.31% -15.48% -7.31%
Gross Profit Margin 77.24% 76.7% 81.46%
Selling, General & Admin $10.28M $8.657M $7.100M
YoY Change 11.76% 21.93% -17.44%
% of Gross Profit 9.81% 8.78% 6.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $45.08M $45.05M $44.21M
YoY Change 2.22% 1.89% 2.59%
% of Gross Profit 43.02% 45.67% 37.88%
Operating Expenses $60.37M $58.78M $56.60M
YoY Change 3.2% 3.85% -1.22%
Operating Profit $44.41M $39.85M $60.10M
YoY Change -33.42% -33.69% -12.39%
Interest Expense -$38.94M -$28.26M -$20.80M
YoY Change 49.2% 35.87% -30.43%
% of Operating Profit -87.68% -70.91% -34.61%
Other Income/Expense, Net -$13.00K $19.00K $2.691M
YoY Change -93.5% -99.29% -700.67%
Pretax Income -$23.82M $14.33M $33.56M
YoY Change -165.27% -57.29% 35.76%
Income Tax $531.0K $92.00K -$138.0K
% Of Pretax Income 0.64% -0.41%
Net Earnings -$24.35M $10.22M $36.46M
YoY Change -165.64% -71.96% 56.6%
Net Earnings / Revenue -17.95% 7.95% 25.45%
Basic Earnings Per Share $0.05 $0.18
Diluted Earnings Per Share -$107.0K $0.05 $0.18
COMMON SHARES
Basic Shares Outstanding 228.7M shares 220.9M shares 205.8M shares
Diluted Shares Outstanding 222.1M shares 206.7M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $112.0M $546.3M $35.00M
YoY Change 89.5% 1460.97% 19.05%
Cash & Equivalents $112.0M $546.3M $35.03M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $250.1M $683.5M $194.9M
YoY Change 13.84% 250.7% 24.06%
LONG-TERM ASSETS
Property, Plant & Equipment $5.163B $5.229B $5.306B
YoY Change -2.31% -1.46% -0.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $96.68M $109.9M $293.8M
YoY Change -66.52% -62.58% -9.41%
Other Assets $3.890M $5.080M $6.800M
YoY Change -39.22% -25.29% -33.33%
Total Long-Term Assets $5.717B $5.526B $5.797B
YoY Change -0.86% -4.67% -1.93%
TOTAL ASSETS
Total Short-Term Assets $250.1M $683.5M $194.9M
Total Long-Term Assets $5.717B $5.526B $5.797B
Total Assets $5.967B $6.210B $5.992B
YoY Change -0.32% 3.64% -1.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $121.5M $108.6M $125.6M
YoY Change -6.69% -13.51% 36.37%
Accrued Expenses $21.50M $18.20M $18.10M
YoY Change 33.54% 0.55% 84.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $143.0M $126.8M $143.7M
YoY Change -2.26% -11.74% 41.02%
LONG-TERM LIABILITIES
Long-Term Debt $2.394B $2.702B $2.423B
YoY Change 0.93% 11.52% -6.92%
Other Long-Term Liabilities $49.71M $51.53M $60.60M
YoY Change -13.84% -14.97% -24.81%
Total Long-Term Liabilities $2.444B $2.754B $2.484B
YoY Change 0.58% 10.87% -7.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $143.0M $126.8M $143.7M
Total Long-Term Liabilities $2.444B $2.754B $2.484B
Total Liabilities $2.587B $2.880B $2.627B
YoY Change 0.42% 9.64% -5.68%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $2.304M $2.209M $2.069M
YoY Change 9.4% 6.77% 6.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.380B $3.329B $3.364B
YoY Change
Total Liabilities & Shareholders Equity $5.967B $6.210B $5.992B
YoY Change -0.32% 3.64% -1.26%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$24.35M $10.22M $36.46M
YoY Change -165.64% -71.96% 56.6%
Depreciation, Depletion And Amortization $45.08M $45.05M $44.21M
YoY Change 2.22% 1.89% 2.59%
Cash From Operating Activities $97.93M $106.2M $96.90M
YoY Change 9.54% 9.59% 13.87%
INVESTING ACTIVITIES
Capital Expenditures -$37.33M -$9.000K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$221.5M -$149.0K -$31.60M
YoY Change 3654.2% -99.53% 618.18%
Cash From Investing Activities -$258.8M -$158.0K -$31.50M
YoY Change 4213.83% -99.5% 62.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -274.6M 371.6M -60.40M
YoY Change 356.95% -715.19% -27.66%
NET CHANGE
Cash From Operating Activities 97.93M 106.2M 96.90M
Cash From Investing Activities -258.8M -158.0K -31.50M
Cash From Financing Activities -274.6M 371.6M -60.40M
Net Change In Cash -435.5M 477.6M 5.000M
YoY Change -1969.21% 9452.16% -128.09%
FREE CASH FLOW
Cash From Operating Activities $97.93M $106.2M $96.90M
Capital Expenditures -$37.33M -$9.000K $0.00
Free Cash Flow $135.3M $106.2M $96.90M
YoY Change 51.3% 9.6% -3.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Central Index Key
EntityCentralIndexKey
0001492298
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
CY2020Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34950
dei Entity Registrant Name
EntityRegistrantName
SABRA HEALTH CARE REIT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2560479
dei Entity Address Address Line1
EntityAddressAddressLine1
18500 Von Karman Avenue, Suite 550
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
393-8248
dei Security12b Title
Security12bTitle
Common stock, $.01 par value
dei Trading Symbol
TradingSymbol
SBRA
CY2021Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
805260000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
681657000 USD
CY2021Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5228677000 USD
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
228678092 shares
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5285038000 USD
CY2021Q3 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
105896000 USD
CY2020Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
102839000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
109944000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
288761000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
546338000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59076000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5080000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6447000 USD
CY2021Q3 sbra Finite Lived Intangible Assets Leases Net
FiniteLivedIntangibleAssetsLeasesNet
76430000 USD
CY2020Q4 sbra Finite Lived Intangible Assets Leases Net
FiniteLivedIntangibleAssetsLeasesNet
82796000 USD
CY2021Q3 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
137181000 USD
CY2020Q4 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
160646000 USD
CY2021Q3 us-gaap Assets
Assets
6209546000 USD
CY2020Q4 us-gaap Assets
Assets
5985603000 USD
CY2021Q3 us-gaap Secured Debt
SecuredDebt
76968000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
79065000 USD
CY2021Q3 us-gaap Loans Payable To Bank
LoansPayableToBank
593625000 USD
CY2020Q4 us-gaap Loans Payable To Bank
LoansPayableToBank
1044916000 USD
CY2021Q3 us-gaap Unsecured Debt
UnsecuredDebt
2031494000 USD
CY2020Q4 us-gaap Unsecured Debt
UnsecuredDebt
1248393000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
126828000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
146276000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Below Market Lease Net
BelowMarketLeaseNet
51531000 USD
CY2020Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
57725000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
2880446000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2576375000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1001238000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2209000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2106000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4344273000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4163228000 USD
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
220858092 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
220858092 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
210560815 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
210560815 shares
CY2020Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
716195000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16144000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39911000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3329100000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3409228000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6209546000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5985603000 USD
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
85367000 USD
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
100612000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
309533000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
319851000 USD
CY2021Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
3405000 USD
CY2020Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
3299000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
9377000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8756000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39819000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39341000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114978000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117908000 USD
CY2021Q3 us-gaap Revenues
Revenues
128591000 USD
CY2020Q3 us-gaap Revenues
Revenues
143252000 USD
us-gaap Revenues
Revenues
433888000 USD
us-gaap Revenues
Revenues
446515000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45046000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44209000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133912000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
132579000 USD
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
24243000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
24904000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
72956000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
75900000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8683000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7216000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26432000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24650000 USD
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-26000 USD
CY2020Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-90000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1890000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
706000 USD
CY2021Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
495000 USD
CY2020Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3154000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
495000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3154000 USD
CY2021Q3 sbra Operating And Interest Expense
OperatingAndInterestExpense
114277000 USD
CY2020Q3 sbra Operating And Interest Expense
OperatingAndInterestExpense
112387000 USD
sbra Operating And Interest Expense
OperatingAndInterestExpense
339502000 USD
sbra Operating And Interest Expense
OperatingAndInterestExpense
335446000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-913000 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-139000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1760000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-531000 USD
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
277000 USD
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
115000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
386000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2308000 USD
CY2021Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
655000 USD
CY2020Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
2715000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-1784000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
2828000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2691000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3158000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4605000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14333000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
33556000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
91228000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
115674000 USD
CY2021Q3 sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-4018000 USD
CY2020Q3 sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
2766000 USD
sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-178817000 USD
sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-13037000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
92000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-138000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1314000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1337000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10223000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
36460000 USD
us-gaap Net Income Loss
NetIncomeLoss
-88903000 USD
us-gaap Net Income Loss
NetIncomeLoss
101300000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220865518 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205791699 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216227221 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205592806 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222063910 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206727167 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
216227221 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206442674 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10223000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
36460000 USD
us-gaap Net Income Loss
NetIncomeLoss
-88903000 USD
us-gaap Net Income Loss
NetIncomeLoss
101300000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
453000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-359000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
814000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
23783000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-37596000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-423000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
6830000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
30000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6471000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23767000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36782000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10253000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
42931000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65136000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
64518000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
3361251000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
36460000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6471000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1625000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20920000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2020Q3 us-gaap Dividends Common Stock
DividendsCommonStock
62387000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
3364340000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3383063000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
10223000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
30000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3124000 USD
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-383000 USD
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q3 us-gaap Dividends Common Stock
DividendsCommonStock
66957000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3329100000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
3488460000 USD
us-gaap Net Income Loss
NetIncomeLoss
101300000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36782000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7582000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21625000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.05
us-gaap Dividends Common Stock
DividendsCommonStock
217678000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
3364340000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3409228000 USD
us-gaap Net Income Loss
NetIncomeLoss
-88903000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23767000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8816000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
172332000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.90
us-gaap Dividends Common Stock
DividendsCommonStock
196140000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3329100000 USD
us-gaap Net Income Loss
NetIncomeLoss
-88903000 USD
us-gaap Net Income Loss
NetIncomeLoss
101300000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133912000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
132579000 USD
sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
10113000 USD
sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
1340000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1444000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1743000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5389000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6527000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6987000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5651000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1760000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-531000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1890000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
706000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-1784000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
2828000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
495000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3154000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
164126000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-14691000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13037000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
11318000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13062000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3523000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5403000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2594000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
258459000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
265455000 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
62116000 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
92945000 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
1651000 USD
sbra Payments For Preferred Equity Investments
PaymentsForPreferredEquityInvestments
4153000 USD
sbra Payments For Preferred Equity Investments
PaymentsForPreferredEquityInvestments
20059000 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
29278000 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
32416000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
2432000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
3095000 USD
sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-683000 USD
sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-3399000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
15066000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8754000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1305000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77366000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-130518000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
56000000 USD
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
791520000 USD
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 USD
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
455000000 USD
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
0 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2185000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2396000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7444000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
819000 USD
sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
172188000 USD
sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
20961000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
194311000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
215747000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
304768000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-142001000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
485861000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7064000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-230000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65523000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49143000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551418000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41849000 USD
us-gaap Interest Paid Net
InterestPaidNet
66051000 USD
us-gaap Interest Paid Net
InterestPaidNet
67995000 USD
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
20731000 USD
us-gaap Transfer Mortgage Payable
TransferMortgagePayable
0 USD
us-gaap Transfer Mortgage Payable
TransferMortgagePayable
31830000 USD
sbra Temporary Rent Deferrals Pandemic Related Number Of Tenants
TemporaryRentDeferralsPandemicRelatedNumberOfTenants
5 tenant
sbra Temporary Rent Deferrals Pandemic Related Amount
TemporaryRentDeferralsPandemicRelatedAmount
2200000 USD
sbra Proceeds From Government Assistance
ProceedsFromGovernmentAssistance
500000 USD
CY2021Q3 sbra Real Estate Investments Joint Ventures Number
RealEstateInvestmentsJointVenturesNumber
0 investment
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
CY2021Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6033937000 USD
CY2021Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
805260000 USD
CY2021Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5228677000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5966695000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
681657000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5285038000 USD
CY2021Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5175051000 USD
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5120598000 USD
CY2021Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
259827000 USD
CY2020Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
249034000 USD
CY2021Q3 us-gaap Land Improvements
LandImprovements
3151000 USD
CY2020Q4 us-gaap Land Improvements
LandImprovements
2220000 USD
CY2021Q3 us-gaap Land
Land
595908000 USD
CY2020Q4 us-gaap Land
Land
594843000 USD
CY2021Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6033937000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5966695000 USD
CY2021Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
805260000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
681657000 USD
CY2021Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5228677000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5285038000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2021Q3 us-gaap Security Deposit Liability
SecurityDepositLiability
11100000 USD
CY2020Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
17500000 USD
CY2021Q3 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
88000000 USD
CY2020Q4 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
85000000 USD
CY2021Q3 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
17000000 USD
CY2020Q4 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
16900000 USD
CY2021Q3 us-gaap Variable Lease Income
VariableLeaseIncome
4600000 USD
us-gaap Variable Lease Income
VariableLeaseIncome
14200000 USD
CY2020Q3 us-gaap Variable Lease Income
VariableLeaseIncome
5000000 USD
us-gaap Variable Lease Income
VariableLeaseIncome
15700000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
108699000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
416600000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
406675000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
407607000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
399207000 USD
CY2021Q3 sbra Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
1577168000 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
3315956000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
500000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3200000 USD
CY2021Q3 sbra Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
17 loan
CY2021Q3 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
62676000 USD
CY2021Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
58897000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
61357000 USD
CY2021Q3 sbra Financing Receivable Fixed Interest Rate
FinancingReceivableFixedInterestRate
0.079
CY2021Q3 sbra Financing Receivable Effective Interest Rate
FinancingReceivableEffectiveInterestRate
0.079
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4269000 USD
CY2021Q3 sbra Investments Weighted Average Contractual Rate
InvestmentsWeightedAverageContractualRate
0.093
CY2021Q3 sbra Investments Weighted Average Effective Rate
InvestmentsWeightedAverageEffectiveRate
0.094
CY2021Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
113711000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2458000 USD
CY2021Q3 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
62676000 USD
CY2021Q3 us-gaap Notes Receivable Net
NotesReceivableNet
54628000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
58899000 USD
CY2021Q3 sbra Preferred Equity Investments Number
PreferredEquityInvestmentsNumber
8 preferredEquityInvestment
CY2021Q3 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
51035000 USD
CY2021Q3 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
51268000 USD
CY2020Q4 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
43940000 USD
CY2021Q3 sbra Preferred Equity Investment Weighted Average Contractual Rate
PreferredEquityInvestmentWeightedAverageContractualRate
0.112
CY2021Q3 sbra Preferred Equity Investment Weighted Average Effective Rate
PreferredEquityInvestmentWeightedAverageEffectiveRate
0.112
CY2021Q3 sbra Number Of Investments
NumberOfInvestments
25 investment
CY2021Q3 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
105896000 USD
CY2020Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
102839000 USD
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
0 USD
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1800000 USD
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-100000 USD
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
700000 USD
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4300000 USD
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
24200000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
73000000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
24900000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
75900000 USD
CY2021Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1700000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5400000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2100000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6500000 USD
CY2021Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
18200000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
16100000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
16280000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2412000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2478000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
900882000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2615000 USD
CY2021Q3 sbra Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1801730000 USD
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2726397000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
2954000 USD
CY2021Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
21356000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
2702087000 USD
CY2021Q3 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-203000 USD
CY2020Q3 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
879000 USD
sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
13642000 USD
sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-38794000 USD
CY2021Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
2319000 USD
CY2021Q3 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2021Q3 us-gaap Derivative Assets
DerivativeAssets
2319000 USD
CY2021Q3 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
1021000 USD
CY2021Q3 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2021Q3 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
1298000 USD
CY2021Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
7273000 USD
CY2021Q3 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2021Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
7273000 USD
CY2021Q3 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
1021000 USD
CY2021Q3 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2021Q3 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
6252000 USD
CY2020Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
7420000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
12802000 USD
CY2020Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
12802000 USD
CY2020Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
5382000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
37018000 USD
CY2020Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
37018000 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
7420000 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
29598000 USD
CY2021Q3 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
62676000 USD
CY2020Q4 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
65320000 USD
CY2021Q3 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
51035000 USD
CY2020Q4 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
43724000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1900000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
900000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10223000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36460000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-88903000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
101300000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220865518 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205791699 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216227221 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205592806 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1198392 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
935468 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
849868 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222063910 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206727167 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
216227221 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206442674 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49

Files In Submission

Name View Source Status
0001492298-21-000050-index-headers.html Edgar Link pending
0001492298-21-000050-index.html Edgar Link pending
0001492298-21-000050.txt Edgar Link pending
0001492298-21-000050-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
sbra-20210930.htm Edgar Link pending
sbra-20210930.xsd Edgar Link pending
sbra-20210930_cal.xml Edgar Link unprocessable
sbra-20210930_def.xml Edgar Link unprocessable
sbra-20210930_htm.xml Edgar Link completed
sbra-20210930_lab.xml Edgar Link unprocessable
sbra-20210930_pre.xml Edgar Link unprocessable
sbraex221.htm Edgar Link pending
sbraex3112021q3.htm Edgar Link pending
sbraex3122021q3.htm Edgar Link pending
sbraex3212021q3.htm Edgar Link pending
sbraex3222021q3.htm Edgar Link pending
Show.js Edgar Link pending